vs

Side-by-side financial comparison of APOGEE ENTERPRISES, INC. (APOG) and AMICUS THERAPEUTICS, INC. (FOLD). Click either name above to swap in a different company.

APOGEE ENTERPRISES, INC. is the larger business by last-quarter revenue ($351.4M vs $185.2M, roughly 1.9× AMICUS THERAPEUTICS, INC.). APOGEE ENTERPRISES, INC. runs the higher net margin — 4.7% vs 0.9%, a 3.8% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 1.6%). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 2.9%).

Apogee Electronics is an American manufacturer of audio interfaces, analog-to-digital and digital-to-analog converters, USB & iOS microphones, and audio production software.

Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.

APOG vs FOLD — Head-to-Head

Bigger by revenue
APOG
APOG
1.9× larger
APOG
$351.4M
$185.2M
FOLD
Growing faster (revenue YoY)
FOLD
FOLD
+22.1% gap
FOLD
23.7%
1.6%
APOG
Higher net margin
APOG
APOG
3.8% more per $
APOG
4.7%
0.9%
FOLD
Faster 2-yr revenue CAGR
FOLD
FOLD
Annualised
FOLD
29.5%
2.9%
APOG

Income Statement — Q4 FY2026 vs Q4 FY2025

Metric
APOG
APOG
FOLD
FOLD
Revenue
$351.4M
$185.2M
Net Profit
$16.6M
$1.7M
Gross Margin
22.4%
85.7%
Operating Margin
7.3%
8.6%
Net Margin
4.7%
0.9%
Revenue YoY
1.6%
23.7%
Net Profit YoY
568.8%
-88.5%
EPS (diluted)
$0.78
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APOG
APOG
FOLD
FOLD
Q1 26
$351.4M
Q4 25
$348.6M
$185.2M
Q3 25
$358.2M
$169.1M
Q2 25
$346.6M
$154.7M
Q1 25
$345.7M
$125.2M
Q4 24
$341.3M
$149.7M
Q3 24
$342.4M
$141.5M
Q2 24
$331.5M
$126.7M
Net Profit
APOG
APOG
FOLD
FOLD
Q1 26
$16.6M
Q4 25
$16.5M
$1.7M
Q3 25
$23.6M
$17.3M
Q2 25
$-2.7M
$-24.4M
Q1 25
$2.5M
$-21.7M
Q4 24
$21.0M
$14.7M
Q3 24
$30.6M
$-6.7M
Q2 24
$31.0M
$-15.7M
Gross Margin
APOG
APOG
FOLD
FOLD
Q1 26
22.4%
Q4 25
23.8%
85.7%
Q3 25
23.1%
88.5%
Q2 25
21.7%
90.2%
Q1 25
21.6%
90.7%
Q4 24
26.1%
90.1%
Q3 24
28.4%
90.6%
Q2 24
29.8%
91.1%
Operating Margin
APOG
APOG
FOLD
FOLD
Q1 26
7.3%
Q4 25
7.1%
8.6%
Q3 25
7.5%
20.3%
Q2 25
2.0%
-6.1%
Q1 25
1.8%
-6.3%
Q4 24
8.4%
10.7%
Q3 24
12.3%
15.3%
Q2 24
12.5%
11.8%
Net Margin
APOG
APOG
FOLD
FOLD
Q1 26
4.7%
Q4 25
4.7%
0.9%
Q3 25
6.6%
10.2%
Q2 25
-0.8%
-15.8%
Q1 25
0.7%
-17.3%
Q4 24
6.1%
9.8%
Q3 24
8.9%
-4.8%
Q2 24
9.4%
-12.4%
EPS (diluted)
APOG
APOG
FOLD
FOLD
Q1 26
$0.78
Q4 25
$0.77
$0.00
Q3 25
$1.10
$0.06
Q2 25
$-0.13
$-0.08
Q1 25
$0.12
$-0.07
Q4 24
$0.96
$0.05
Q3 24
$1.40
$-0.02
Q2 24
$1.41
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APOG
APOG
FOLD
FOLD
Cash + ST InvestmentsLiquidity on hand
$39.5M
$293.5M
Total DebtLower is stronger
$232.3M
$392.7M
Stockholders' EquityBook value
$511.8M
$274.2M
Total Assets
$1.1B
$949.9M
Debt / EquityLower = less leverage
0.45×
1.43×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APOG
APOG
FOLD
FOLD
Q1 26
$39.5M
Q4 25
$41.3M
$293.5M
Q3 25
$39.5M
$263.8M
Q2 25
$32.8M
$231.0M
Q1 25
$41.4M
$250.6M
Q4 24
$43.9M
$249.9M
Q3 24
$51.0M
$249.8M
Q2 24
$30.4M
$260.1M
Total Debt
APOG
APOG
FOLD
FOLD
Q1 26
$232.3M
Q4 25
$392.7M
Q3 25
$392.0M
Q2 25
$391.3M
Q1 25
$285.0M
$390.7M
Q4 24
$390.1M
Q3 24
$389.5M
Q2 24
$388.9M
Stockholders' Equity
APOG
APOG
FOLD
FOLD
Q1 26
$511.8M
Q4 25
$512.3M
$274.2M
Q3 25
$500.2M
$230.4M
Q2 25
$481.8M
$204.3M
Q1 25
$487.9M
$193.6M
Q4 24
$522.1M
$194.0M
Q3 24
$506.4M
$178.8M
Q2 24
$480.0M
$132.5M
Total Assets
APOG
APOG
FOLD
FOLD
Q1 26
$1.1B
Q4 25
$1.1B
$949.9M
Q3 25
$1.2B
$868.8M
Q2 25
$1.2B
$815.3M
Q1 25
$1.2B
$789.8M
Q4 24
$1.2B
$785.0M
Q3 24
$917.1M
$786.6M
Q2 24
$889.0M
$749.5M
Debt / Equity
APOG
APOG
FOLD
FOLD
Q1 26
0.45×
Q4 25
1.43×
Q3 25
1.70×
Q2 25
1.92×
Q1 25
0.58×
2.02×
Q4 24
2.01×
Q3 24
2.18×
Q2 24
2.93×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APOG
APOG
FOLD
FOLD
Operating Cash FlowLast quarter
$122.5M
$16.3M
Free Cash FlowOCF − Capex
$16.0M
FCF MarginFCF / Revenue
8.6%
Capex IntensityCapex / Revenue
7.8%
0.2%
Cash ConversionOCF / Net Profit
7.37×
9.62×
TTM Free Cash FlowTrailing 4 quarters
$29.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APOG
APOG
FOLD
FOLD
Q1 26
$122.5M
Q4 25
$29.3M
$16.3M
Q3 25
$57.1M
$35.7M
Q2 25
$-19.8M
$-26.5M
Q1 25
$30.0M
$7.8M
Q4 24
$31.0M
$-3.9M
Q3 24
$58.7M
$-23.0M
Q2 24
$5.5M
$22.7M
Free Cash Flow
APOG
APOG
FOLD
FOLD
Q1 26
Q4 25
$22.9M
$16.0M
Q3 25
$52.4M
$35.3M
Q2 25
$-26.9M
$-28.9M
Q1 25
$19.1M
$7.5M
Q4 24
$22.0M
$-4.2M
Q3 24
$50.2M
$-23.3M
Q2 24
$-1.8M
$21.6M
FCF Margin
APOG
APOG
FOLD
FOLD
Q1 26
Q4 25
6.6%
8.6%
Q3 25
14.6%
20.9%
Q2 25
-7.8%
-18.7%
Q1 25
5.5%
6.0%
Q4 24
6.4%
-2.8%
Q3 24
14.7%
-16.5%
Q2 24
-0.5%
17.0%
Capex Intensity
APOG
APOG
FOLD
FOLD
Q1 26
7.8%
Q4 25
1.9%
0.2%
Q3 25
1.3%
0.2%
Q2 25
2.1%
1.6%
Q1 25
3.2%
0.2%
Q4 24
2.6%
0.2%
Q3 24
2.5%
0.3%
Q2 24
2.2%
0.9%
Cash Conversion
APOG
APOG
FOLD
FOLD
Q1 26
7.37×
Q4 25
1.77×
9.62×
Q3 25
2.41×
2.06×
Q2 25
Q1 25
12.08×
Q4 24
1.48×
-0.27×
Q3 24
1.92×
Q2 24
0.18×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

APOG
APOG

Architectural Services$127.1M36%
Architectural Metals$110.0M31%
Architectural Glass$67.4M19%
Performance Surfaces$54.3M15%

FOLD
FOLD

Other$105.8M57%
Galafold$64.8M35%
Pombiliti Opfolda$14.6M8%

Related Comparisons